Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Aclaris Therapeutics started by the founders of Vicept Therapeutics, is a privately held specialty pharmaceutical dermatology company focused on the development of novel dermatologic therapies. It is committed to identifying, developing, and commercializing innovative therapies to address significant unmet needs in dermatology, both medical and aesthetic, and immunology. Aclaris is focused on market segments with no FDA-approved medications or where treatment gaps exist.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 9, 2015 | Series C | $40M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Mossrock Capital | — | Series C |